CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


24-May-2016
Cerilliant now offers Certified Spiking Solutions® of the benzodiazepine internal standards Flurazepam-D4 and 7-Aminoflunitrazepam-13C6.

7-Aminoflunitrazepam-13C6, A-111
100 µg/mL in Acetonitrile

This stable-labeled internal standard is suitable for quantitation of 7-aminoflunitrazepam levels by LC-MS/MS methods for clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring or isotope dilution applications. 7-Aminoflunitrazepam is a major urinary metabolite of flunitrazepam, sold under the trade name Rohypnol. Flunitrazepam is an intermediate-acting benzodiazepine prescribed for the treatment of severe insomnia. For these analyses, 13C-labeled internal standards can eliminate potential issues of isotopic exchange and minimize separation of later-eluting analytes from a higher substituted deuterium-labeled internal standard.

Flurazepam-D4, 100 µg/mL, 1 mL F-044
100 ug/mL in Methanol

Flurazepam is a long acting benzodiazepine that is used to treat mild to moderate insomnia. This stable-labeled internal standard is suitable for quantitation of flurazepam levels in GC/MS or LC/MS methods for clinical toxicology, forensic analysis, urine drug testing, pain prescription monitoring or isotope dilution applications. 



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn